Tag: regulatory compliance

Toronto, Canada, June 12, 2025 (GLOBE NEWSWIRE) -- In a significant step toward mainstreaming crypto-based passive income, Coinchange and Kanga Exchange have joined forces to offer automated yield solutions—resulting in over 30% user adoption in just months. The partnership between Coinchange, a digital asset management platform, and Kanga Exchange, a leading cryptocurrency exchange platform, demonstrates how the integration of yield-generating solutions can simplify access to passive income opportunities. The collaboration has enabled over 30% of Kanga’s active users to generate passive income through multi-strategy active portfolio management solutions on their digital asset holdings without requiring active supervision or technical expertise.

Driven by Stable Legacy Sales and Ongoing Cost Savings Initiatives

BRUSSELS and CAMBRIDGE, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- UCB (Euronext Brussels: UCB) and Biogen Inc. (NASDAQ: BIIB) today presented additional detailed results from the Phase 3 PHOENYCS GO study evaluating dapirolizumab pegol (DZP), a novel Fc-free anti-CD40L drug candidate. In the study, DZP demonstrated significant clinical improvements in disease activity in people living with moderate-to-severe systemic lupus erythematosus (SLE), as measured by the British Isles Lupus Assessment Group (BILAG)-based Composite Lupus Assessment (BICLA) at Week 48, the primary endpoint. Improvements were also seen across additional clinical measures, including fatigue and disease activity/remission. These results were presented at EULAR 2025, the European Alliance of Associations for Rheumatology’s annual meeting, in Barcelona, Spain. The safety and efficacy of DZP in SLE have not been established, and it is not approved for use in SLE by any regulatory authority worldwide. A second Phase 3 trial of dapirolizumab pegol is ongoing with the goal of confirming the results from PHOENYCS GO.

New York City, June 11, 2025 (GLOBE NEWSWIRE) -- Financial crises impact millions of Americans each year, too often leaving people with poor credit choices navigating for instant funding alternatives. Low Credit Finance, an online lending marketplace, has created a $500 loan product tailored to subprime borrowers who have poor credit records. The product takes advantage of the increased need for affordable emergency lending among consumers who do not qualify for conventional bank loans.

DALLAS, June 11, 2025 (GLOBE NEWSWIRE) -- Lewis & Ellis, Inc. ("Lewis & Ellis"), a leading actuarial consulting firm, announced today it is joining forces with Huggins Actuarial Services, Inc. ("Huggins"), significantly expanding their combined actuarial capabilities within the property & casualty (P&C) insurance market. This partnership unites two highly respected firms dedicated to providing innovative actuarial solutions and exceptional client service.